PHC Corporation signed an exclusive agreement with MaxCyte to distribute its platform in Japan, with operations launched in Singapore.
1 report, 0 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
PHC Corporation signed an exclusive agreement with MaxCyte to distribute its platform in Japan, with operations launched in Singapore.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
PHC Corporation (Japan)
company in Chuo, Japan
Nothing else this week.
-
MaxCyte (United States)
Biotech company in Rockville, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet